A RELIABILITY STUDY OF SLEDAI - A DISEASE-ACTIVITY INDEX FOR SYSTEMIC LUPUS-ERYTHEMATOSUS

被引：0
|
作者：
HAWKER, G
GABRIEL, S
BOMBARDIER, C
GOLDSMITH, C
CARON, D
GLADMAN, D
机构：
[1] WELLESLEY COLL HOSP, DEPT MED, DIV RHEUMATOL, TORONTO M4Y 1J3, ONTARIO, CANADA
[2] MAYO CLIN & MAYO FDN, DEPT MED, DIV RHEUMATOL, ROCHESTER, MN 55905 USA
[3] MCMASTER UNIV, DEPT CLIN EPIDEMIOL & BIOSTAT, HAMILTON L8S 4L8, ONTARIO, CANADA
[4] WELLESLEY COLL HOSP, CLIN EPIDEMIOL UNIT, TORONTO M4Y 1J3, ONTARIO, CANADA
来源：
JOURNAL OF RHEUMATOLOGY | 1993年 / 20卷 / 04期
关键词：
LUPUS DISEASE ACTIVITY; SLEDAI; OUTCOME MEASURES;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SLEDAI, a disease activity index for systemic lupus erythematosus (SLE) has been validated against other such indices and its reliability has been shown by specialists in SLE. To assess its reliability among less experienced clinicians, we conducted a reliability study 3 rheumatology trainees and 9 patients with SLE according to a Latin square design. SLEDAI easily distinguished between patients (p = 0.0009), and physician variability was not statistically significant (p = 0.27). Inter and intraobserver agreement were 78.7 and 98.0%, respectively. SLEDAI was thus shown to be a reliable instrument among less experienced observers for the assessment of disease activity in SLE.
引用
收藏
页码：657 / 660
页数：4
相关论文
共 50 条
  • [41] TRANSIENT MYOPIA WITH SEVERE CHEMOSIS ASSOCIATED WITH EXACERBATION OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SHU, U
    TAKEUCHI, F
    TANIMOTO, K
    MOROI, Y
    UCHIDA, KI
    ITO, K
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (02) : 297 - 302
  • [42] PROLACTIN IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - EFFECT OF DISEASE-ACTIVITY AND RENAL-FUNCTION
    KARLING, D
    ASCH, E
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S230 - S230
  • [43] SKELETAL-MUSCLE LYMPHOCYTIC VASCULITIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RELATION TO DISEASE-ACTIVITY
    LIM, KL
    LOWE, J
    POWELL, RJ
    LUPUS, 1995, 4 (02) : 148 - 151
  • [44] SERUM-SOLUBLE MARKERS OF IMMUNE ACTIVATION AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SAMSONOV, MY
    TILZ, GP
    EGOROVA, O
    REIBNEGGER, G
    BALABANOVA, RM
    NASSONOV, EL
    NASSONOVA, VA
    WACHTER, H
    FUCHS, D
    LUPUS, 1995, 4 (01) : 29 - 32
  • [45] C4A ANAPHYLATOXIN LEVELS AS AN INDICATOR OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    WILD, G
    WATKINS, J
    WARD, AM
    HUGHES, P
    HUME, A
    ROWELL, NR
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 80 (02): : 167 - 170
  • [46] C-REACTIVE PROTEIN AND SEROLOGICAL INDEXES OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    BERTOUCH, JV
    ROBERTSTHOMPSON, PJ
    FENG, PH
    BRADLEY, J
    ANNALS OF THE RHEUMATIC DISEASES, 1983, 42 (06) : 655 - 658
  • [47] PNEUMOCOCCAL ANTIBODY-LEVELS VARY WITH DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    CHUDWIN, DS
    LANGLOIS, P
    GAWRYL, M
    ANNALS OF ALLERGY, 1988, 60 (02): : 168 - 168
  • [48] EVALUATION OF 2 DISEASE-ACTIVITY INDEXES OF SYSTEMIC LUPUS-ERYTHEMATOSUS IN PEDIATRIC-PATIENTS
    MERINO, R
    GARCIACONSUEGRA, J
    MENDEZ, S
    MADERO, R
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1995, 13 (05) : 680 - 681
  • [49] SENSITIVITY TO CHANGE OF 3 SYSTEMIC LUPUS-ERYTHEMATOSUS DISEASE-ACTIVITY INDEXES - INTERNATIONAL VALIDATION
    GLADMAN, DD
    GOLDSMITH, CH
    UROWITZ, MB
    BACON, P
    BOMBARDIER, C
    ISENBERG, D
    KALUNIAN, K
    LIANG, MH
    MADDISON, P
    NIVED, O
    RICHTER, M
    SNAITH, M
    SYMMONS, D
    ZOMA, A
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (08) : 1468 - 1471
  • [50] CALPROTECTIN IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - RELATION TO CLINICAL AND LABORATORY PARAMETERS OF DISEASE-ACTIVITY
    HAGA, HJ
    BRUN, JG
    BERNTZEN, HB
    CERVERA, R
    KHAMASHTA, M
    HUGHES, GRV
    LUPUS, 1993, 2 (01) : 47 - 50
12345